期刊文献+

慢性NK细胞增多症患者临床及实验室特征分析——八例报告并文献复习 被引量:1

Chronic natural killer cell lymphocytosis: eight cases report and literature review
原文传递
导出
摘要 目的 提高对慢性NK细胞增多症(CNKL)的认识.方法 结合相关文献和8例患者资料对CNKL患者的临床及实验室特征进行分析.结果 8例患者确诊时中位年龄55.5(28~ 75)岁,大多数患者临床症状轻微,4例患者诊断时无临床症状.血常规异常主要表现为白细胞[中位值11.8(4.5 ~20.7)×109/L]及淋巴细胞比例[中位值0.78(0.51~0.89)]增高,少数患者伴有贫血或血小板减少.流式细胞术检测外周血NK细胞(CD3-CD 16+细胞)计数增高[中位值5.7(2.4~9.6)×109/L].8例患者中1例失访,4例未给予治疗,3例患者分别给予苯丁酸氮芥、甲泼尼龙、泼尼松治疗,获得较好治疗反应.中位随访47(11~78)个月,7例患者病情稳定.结论 CNKL患者临床症状轻微,外周血NK细胞(CD3 CD16+细胞)增多,预后较好. Objective To identify the characteristics of chronic natural killer cell lymphocytosis (CNKL).Methods The clinical data of eight cases defined by the World Health Organization classification was retrospectively analyzed and related literatures were reviewed.Results Half of the 8 patients were asymptomatic.Among them,the most common abnormalities were leukocytosis with the median of 11.8 (4.5-20.0) × 109/L and high proportion of lymphocytes [0.78 (0.51-0.89)],while anemia and thrombocytopenia only in 1 patient respectively.The absolute CD3-CD16+ NK cell count with the median of 5.7 (2.4-9.6) × 109/L increased in peripheral blood.By the end of follow-up,except one case was lost,the other seven patients were in stable condition,including four cases without any medications and three patients receiving chlorambucil or glucocorticoid.Conclusions As an indolent chronic lymphoproliferative disease,CNKL was presented with mild clinical symptoms and increased number of CD3 CD16 + NK cells in peripheral blood.Patients with symptoms could be treated with immunosuppressive therapy while those asymptomatic could be followed up without intervention.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2014年第7期609-613,共5页 Chinese Journal of Hematology
基金 天津市科委应用基础及前沿技术研究计划(11JCY-BJC10500) 国家科技重大专项(重大新药创制)(2011ZX09302-007-04) 卫生公益性行业科研专项(201202017)
关键词 杀伤细胞 天然 淋巴细胞增殖性疾病 慢性NK细胞增多症 Killer cell, natural Lymphoproliferative disorder Chronic natural killer cell lymphocytosis
  • 相关文献

参考文献17

  • 1Villamor N, Morice WG, Chan WC, et al. Chronic lymphoprolif- erative disorders of NK cells//James W Vardiman. Vardiman.WHO Classification of Tumours of Haematopoietic and Lym- phoid Tissues [S/OL]. 4th ed. France: International Agency for Research on Cancer Press, 2008:274-275.
  • 2Tefferi A. Chronic Natural Killer Cell Lymphocytosis [J]. Leuk Lymphoma, 1996, 20 (3-4) :245-248.
  • 3Tefferi A, Li CY, Witzig TE, et al. Chronic natural killer cell lymphocytosis: a descriptive clinical study [J]. Blood, 1994, 84 (8) :2721-2725.
  • 4Rabbani GR, Phyliky RL, Tefferi A. A long-term study of patients with chronic natural killer cell lymphocytosis [Jl. Br J Haematol, 1999, 106(4):960-966.
  • 5Sivakumaran M, Richards S J, Scott CS. Clinical and laboratory characteristics of chronic natural killer cell lymphocytosis [J]. Blood, 1996, 87(4):1659-1660.
  • 6Lima M, Almeida J, Montero AG, et al. Clinicobiological, immu- nophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocy- tosis[J]. Am J Pathol, 2004, 165(4):1117-1127.
  • 7Sokol L, Loughran TP Jr. Large granular lymphocyte leukemia [J]. Oncologist, 2006, 11(3):263-273.
  • 8Freud AG, Caligiuri MA. Human natural killer cell development [J]. Immunol Rev, 2006, 214( 1 ):56-72.
  • 9Suzuki R, Suzumiya J, Nakamura S, et al. Aggressive natural killer-cell leukaemia revisited:large granular lymphocyte leukaemia of cytotoxic NK ceils [J]. Leukaemia, 2004, 18 (4): 763-770.
  • 10Alekshun TJ,Sokol L. Diseases of large granular lymphocytes[J]. Cancer Control, 2007, 14(2):141-150.

同被引文献12

  • 1Loughran TP. Clonal diseases of large granular lymphocytes [ J ]. Blood, 1993,82( 1 ) : 1 - 14.
  • 2Sokol L, Loughran TP. Large granular lymphocyte leukemia [ J ]. Oneologist ,2006,11 (3) :263 - 273.
  • 3Tefferi A, Li CY, Witzig TE. et al. Chronic natural killer cell lymphocytosis: a descriptive clinical study [ J ]. Blood, 1994, 84 ( 8 ) : 2721 - 2725.
  • 4Rabbani GR, Phyliky RL,Tefferi A. A long-term study of patients with chronic natural killer cell lymphocytosis [ J ]. Br J Haematol, 1999,106 (4) :960 -966.
  • 5Poullot E, Zambello R, Leblanc F, et al. Chronic natural killer lymphoproliferative disorders : characteristics of an international cohort of 70 patients[ J]. Annals of Oncology,2014,25 (10) : 2030 - 2035.
  • 6Suzuki R, Suzumiya J, Nakamura S, et al. Aggressive natural killer cell leukaemia revisited: large granular lymphocyte leukaemia of cytotoxic NK cells [ J ]. Leukaemia,2004,18 (4) :763 - 770.
  • 7Epling Burnette PK, Painter JS, Chaurasia P,et al. Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytcs [ J ]. Blood, 2004,103 ( 9 ) : 3431 - 3439.
  • 8Jercz A,Clcmente M J, Makishima H, et al. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia [ J ]. Blood, 2012,120 ( 15 ) : 3048 - 3057.
  • 9Vanness ER,Davis MDP,Tefferi A. Cutaneous findings associated with the chronic natural killer cell lymphocytosis [ J ]. Int J Derrnatol,2002, 41 (12) :852 - 857.
  • 10Chee CE, Warrington K J, Tefferi A. Chronic natural killer-cell lymphocytosis successfully treated with alemtuzumab [ J ]. Blood, 2009,114 ( 16 ) :3500 - 3502.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部